NCT07812545 Designing Effective Alcohol Health Warnings: An Experimental Study With Adults in the U.S.
| NCT ID | NCT07812545 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Oklahoma |
| Condition | Risk Perceptions |
| Study Type | INTERVENTIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2026-07-27 |
| Primary Completion | 2026-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 2,000 participants in total. It began in 2026-07-27 with a primary completion date of 2026-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Consuming alcohol is a dose-dependent and modifiable risk factor for breast cancer. Although alcohol consumption contributes to an estimated 16% of breast cancer cases, awareness of the link between alcohol and breast cancer risk remains low. Systematically developed and tested health warnings can support population-based approaches and intervention strategies to decrease alcohol consumption and breast cancer risk. For instance, the U.S. Food and Drug Administration can mandate specific warnings through statements (e.g., "WARNING: This product contains nicotine…") and color graphics depicting the negative health consequences of products that can harm public health, such as tobacco and alcohol. However, health warning statements and graphics should be assessed among intended audiences before implementation. Research has outlined principles for effective health warning statements. This project will test different health warning statements about the health effects of alcohol.
Eligibility Criteria
Inclusion Criteria: * being between 18 and 65 years of age * assigned female at birth * self-report having consumed alcohol in the last 30 days for the current drinker groups * self-report not having consumed alcohol in the last 30 days for the nondrinker groups * live in the US and able to read, speak, and understand English
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07812545 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 65 Years, studying Risk Perceptions. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07812545 currently recruiting?
Yes, NCT07812545 is actively recruiting participants. Contact the research team at zachary-massey@ou.edu for enrollment information.
Where is the NCT07812545 trial being conducted?
This trial is being conducted at Oklahoma City, United States.
Who is sponsoring the NCT07812545 clinical trial?
NCT07812545 is sponsored by University of Oklahoma. The trial plans to enroll 2,000 participants.